Day: November 17, 2022

New York, NY, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Maxim Group LLC (“Maxim”) issues Equity Research Report on Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), SEA’s leading data-driven loyalty, fintech and e-commerce ecosystem.  Click here to view the full Maxim Group LLC Equity Research Report. Summary Points: • Positive view of early stages of building SEA ecommerce company. Luxury store Leflair provides luxury goods online. Additional businesses include online delivery companies Handycart and Pushkart (bought during 1Q22), as well as Gorilla Networks, a telecom MVNO (early June 2022). During 3Q22 the company acquired Thoughtful Media, a digital influencer, Mangan.ph, restaurant delivery, and NusaTrip, an online travel agency. SoPa will launch a loyalty points offering. Maxim believes Thoughtful Media can...

Topline proof-of-concept data in vitiligo patients expected in 1H 2023 BRIDGEWATER, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that the first subjects have been dosed in a Phase 1a/b clinical trial evaluating VYN201 for the treatment of vitiligo. VYN201 is a locally administered, small molecule, pan-bromodomain and extra-terminal domain (BET) inhibitor that is being developed for the treatment of immuno-inflammatory diseases. The clinical trial is a first-in-human study designed to generate safety and pharmacokinetic data in healthy volunteers as well as provide early clinical proof-of-concept data in vitiligo...

UPPSALA, Sweden, Nov. 17, 2022 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain at the Biomarkers of the Future conference in Paris, France. Novelties in Biomarkers is an annual award established in 2019 by Olink Proteomics with the purpose of encouraging and motivating young scientists in the use of biomarker discovery in their research. This year’s theme Biomarkers in 2023: Emerging applications attracted over 30 abstract submissions, with participants representing countries from five continents (Africa, Asia, Europe, North America, South America). The abstracts cover more than ten different fields including Infectious diseases, Neurology, Metabolism, Cardiology, Oncology,...

REHOVOT, Israel and WILMINGTON, Del., Nov. 17, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers, today is announcing a poster presentation highlighting interim results from the Phase 2 segment / Part A of the RINGSIDE Pivotal Phase 2/3 clinical trial in desmoid tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting, taking place in-person November 16-19 in Vancouver, Canada. The ongoing RINGSIDE Pivotal Phase 2/3 clinical trial is evaluating the investigational new drug AL102, a potent, selective, oral gamma-secretase inhibitor. Positive interim results from the Phase 2 segment of this study were previously presented at ESMO...

Bank Recognized as an Emerging DEI InfluencerProvident Bank receives The African American Chamber of Commerce of New Jersey and The New Jersey Chamber of Commerce DEI Trailblazer Award. Left to right: Thomas Bracken, President & CEO, New Jersey Chamber of Commerce; Patricia Teffenhart, Senior Vice President, Strategic Initiatives, New Jersey Chamber of Commerce; Carmen Gates, Director of Training and Community Initiatives, African American Chamber of Commerce of New Jersey (AACCNJ); Xavia Mitchell, First Vice President, Senior Diversity & HR Business Partner; Ferlanda Fox Nixon, Esq. Chief of Policy and External Affairs, African American Chamber of Commerce of New Jersey (AACCNJ); John Harmon, Founder, President & CEO, African American Chamber of Commerce of New Jersey (AACCNJ)ISELIN, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE)...

Highlights:Incannex has engaged CMAX Clinical Research and Novotech CRO to undertake a bioavailability/bioequivalence (‘BA/BE’) study to assess the pharmacokinetics and tolerability of IHL-42X in 116 participants Incannex is well progressed in drafting an Investigational New Drug (‘IND’) Application for submission to the US Food and Drug Administration (‘FDA’) in Q1 of 2023 Once the IND is open, Incannex will commence pivotal, multi-site Phase 2/3 clinical trials investigating the effects of IHL-42X in patients with OSA over a 12-month period Phase 2/3 pivotal trials will include between 20 to 30 trial sites, including many in the United States. Sixty-three clinical trial sites have expressed interest in conducting the trial.MELBOURNE, Australia, Nov. 17, 2022 (GLOBE NEWSWIRE) — Incannex Healthcare Limited (Nasdaq: IXHL) (ASX:...

FREMONT, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that installers of Enphase© products in Belgium have seen growing deployments of Enphase Energy Systems™ powered by IQ© Microinverters and IQ™ Batteries. Enphase began shipping its microinverter products to Belgium more than a decade ago, and launched the IQ Battery in the country last year. Installers are increasingly turning to the Enphase Energy System to provide an all-in-one solution with its IQ Batteries and IQ Microinverters, allowing homeowners to store their energy for later use in their homes and avoid rising energy prices. “We strive to offer homeowners in Belgium home energy systems...

CHICAGO, IL, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Epazz Inc. (OTC Pink: EPAZ), a mission-critical provider of metaverse solutions, blockchain cryptocurrency mobile apps, and cloud-based business software solutions, announced today that its On-site Remote Assist (OSRA) product integrated to the Metaverse technology would conduct first practical metaverse application on beta customers in Germany. Following Epazz’s newly acquired client contracts in Germany, the Epazz Metaverse with OSRA integration will deploy the software technology early in January next year.  TillerStack field management software, a member of Epazz Holdings, advances its revolutionary On-Site-Remote Assist product, a precursor to the Metaverse technology integration to real-world applications.  The Epazz’s Metaverse Technology, when...

As a certified partner, Linical will leverage Science 37’s Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network RESEARCH TRIANGLE PARK, N.C. and OSAKA, Japan, Nov. 17, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, and Linical Americas, a U.S. subsidiary of The Linical Group, a leading global contract research organization (CRO), today announced a partnership that will facilitate the deployment of decentralized clinical trial solutions—powered by Science 37—to Linical’s international clients, enabling patient access from virtually anywhere. As part of the collaboration, Linical will integrate Science 37’s virtual site capabilities into its network, to deliver faster, more inclusive, patient-centric trials to global research clients....

Designed with our patented and proven NiTiNOL technology, DynaNail Helix™ revolutionizes dynamic compression in foot & ankle fusionDynaNail Helix Image The new DynaNail Helix™ which is designed with Enovis’ patented and proven NiTiNOL technology.Wilmington, DE, Nov. 17, 2022 (GLOBE NEWSWIRE) — Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the DynaNail Helix™, the latest addition to the DynaNail® family and Enovis’ expansive suite of foot and ankle products. DynaNail Helix is designed to achieve sustained dynamic compression for subtalar fusion with an innovative, anatomically friendly design and simple, screw-like insertion. Leveraging the same groundbreaking NiTiNOL compressive element technology from other DynaNail systems, the...